Working… Menu

Study to Evaluate the Efficacy and Safety Of Intravesical Nanoxel®M In BCG Refractory NMIBC

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02982395
Recruitment Status : Terminated
First Posted : December 5, 2016
Last Update Posted : August 30, 2019
Information provided by (Responsible Party):
Samyang Biopharmaceuticals Corporation

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : August 2018
Actual Study Completion Date : August 2018